Flamel Technologies S.A. (ADR) (NASDAQ:FLML)

CAPS Rating: 5 out of 5

A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.

Recs

0
Player Avatar lowmaple (71.47) Submitted: 10/19/2007 2:01:20 AM : Outperform Start Price: $9.10 FLML Score: -42.27

rebound

Featured Broker Partners


Advertisement